Velacur

DIAGNOSTIC_TEST3 trials

Sponsors

Indiana University, GI Alliance, Emory University

Conditions

Chronic Advanced Liver DiseaseMetabolic Dysfunction Associated Steatotic Liver DiseaseNon-Alcoholic Fatty Liver Disease (NAFLD)Non-alcoholic Fatty Liver Disease (NAFLD)Portal Hypertension

Unknown Phase

Velacur by Sonic Incytes for Portal Hypertension

CompletedNCT04576897

Indiana UniversityChronic Advanced Liver Disease, Portal Hypertension

Start: 2021-02-01End: 2022-04-19Updated: 2023-09-05

Validation Study of the Velacur System in Comparison to MRE & MRI-PDFF in Patients With (Suspected) Liver Disease

GI AllianceNon-alcoholic Fatty Liver Disease (NAFLD)

Start: 2023-07-15End: 2024-01-31Target: 100Updated: 2023-06-18

Non-Invasive Diagnostic Tests for MASLD in Pediatric Population

Active, not recruitingNCT06218589

Emory UniversityMetabolic Dysfunction Associated Steatotic Liver Disease, Non-Alcoholic Fatty Liver Disease (NAFLD)

Start: 2024-01-18End: 2027-02-01Target: 200Updated: 2026-04-08